💊 Clomiphene (Clomiphene Citrate)
Clomiphene is an oral tablet used to treat ovulatory dysfunction in women who wish to become pregnant. It is available by prescription only, and the dose and treatment must be directed by a physician experienced in managing gynecologic or endocrine disorders.
In Arabic: كلوميفين (سترات الكلوميفين)✅ What it is used for
- Treatment of ovulatory dysfunction in women desiring pregnancy
- Patients most likely to respond: polycystic ovary syndrome, amenorrhea-galactorrhea syndrome, psychogenic amenorrhea, post-oral-contraceptive amenorrhea, and certain cases of secondary amenorrhea of undetermined cause
🧪 Active ingredient
Clomiphene citrate: a nonsteroidal agent that interacts with estrogen-receptor-containing tissues (including the hypothalamus, pituitary, ovary, and endometrium). It increases release of pituitary gonadotropins, stimulating follicle growth and ovulation.
🌿 Benefits
- Stimulates ovulation in women with ovulatory dysfunction
- Most patients who are going to ovulate do so after the first course of therapy
📝 How to use
- The dose and duration are set by your doctor or pharmacist and should not be changed without consulting them
- Taken by mouth
- Intercourse should be timed to coincide with the expected time of ovulation; a basal body temperature chart or other tests may help determine if ovulation occurred
- A pelvic exam is needed before each course, and pregnancy, ovarian enlargement, or cysts must be excluded between cycles
- Long-term cyclic therapy is not recommended beyond a total of about six cycles
💊 Dosage forms
- 50 mg tablets (off-white, round, scored)
⚠️ Common side effects
- Ovarian enlargement
- Vasomotor flushes (hot flashes)
- Abdominal/pelvic discomfort, distention, or bloating
- Nausea and vomiting
- Breast discomfort
- Visual symptoms such as blurred vision, lights, floaters, or waves
- Headache
- Abnormal uterine bleeding (intermenstrual spotting, heavy periods)
🚨 Serious — seek medical help
- Persistent or severe visual disturbances (may occasionally be irreversible; stop treatment and seek an eye examination promptly)
- Ovarian hyperstimulation syndrome
- Severe abdominal or pelvic pain with ovarian enlargement
- Postmarketing reports include arrhythmia, chest pain, pulmonary embolism, thrombophlebitis, stroke, seizure, syncope, and allergic skin reactions
- Reports suggest prolonged use may increase the risk of borderline or invasive ovarian tumors
⛔ Do not use if
- Known hypersensitivity to clomiphene citrate or any ingredient
- Pregnancy
- Liver disease or history of liver dysfunction
- Abnormal uterine bleeding of undetermined origin
- Ovarian cysts or enlargement not due to polycystic ovary syndrome
- Uncontrolled thyroid or adrenal dysfunction
- Organic intracranial lesion such as a pituitary tumor
❗ Warnings & precautions
- Visual symptoms may make driving or operating machinery more hazardous, particularly in variable lighting
- Visual symptoms increase with higher total dose or longer treatment duration
- If any visual symptoms occur, discontinue treatment and obtain a complete ophthalmological evaluation
- Risk of ovarian hyperstimulation syndrome, especially in patients with polycystic ovary syndrome
- Evaluate carefully and exclude pregnancy and ovarian cysts before each cycle
- Increasing the dose or duration beyond the recommended limits is not advised
- Prolonged therapy may raise serum desmosterol levels
🔄 Drug interactions
- According to the label, drug interactions with clomiphene citrate have not been documented. Still, tell your doctor or pharmacist about all medicines you take.
🤰 Pregnancy
Use during pregnancy is contraindicated because clomiphene offers no benefit in this population. Available human data do not suggest an increased risk of congenital anomalies above background, but animal studies showed increased embryo-fetal loss and structural malformations. Appropriate tests should be used each cycle to detect ovulation and/or pregnancy. If pregnancy occurs during treatment, the patient should be informed of potential risks to the fetus.
🍼 Breastfeeding
It is not known whether clomiphene is excreted in human milk. Caution should be exercised in nursing women, and the drug may reduce lactation in some patients.
🧒 Children
The drug is indicated for women desiring pregnancy due to ovulatory dysfunction; the label provides no pediatric indication.
👴 Older adults
The label provides no specific information for elderly patients; the drug is intended for women of reproductive age.
🌡️ Storage
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C. Protect from heat, light, and excessive humidity, and keep in a closed container.
⏰ Missed dose
The label gives no specific instructions for a missed dose. Consult your doctor or pharmacist and do not double the dose on your own.
🆘 Overdose
No toxic effects of acute overdose have been reported. Signs of taking more than the recommended dose include nausea, vomiting, flushes, blurred vision, spots or flashes, scotomata, and ovarian enlargement with pelvic or abdominal pain. Seek medical attention immediately; management is supportive along with gastrointestinal decontamination.
💰 Price & brands in your area
Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Clomiphene interacts with estrogen receptors in the hypothalamus, pituitary, ovary, endometrium, vagina, and cervix. It may compete with estrogen for receptor binding and delay replenishment of intracellular estrogen receptors, increasing pituitary gonadotropin release, which initiates steroidogenesis and folliculogenesis, raises estradiol, and leads to a preovulatory gonadotropin surge and follicular rupture. It is a mixture of two geometric isomers (cis zuclomiphene and trans enclomiphene) containing 30–50% cis-isomer.
Labeled dosing
General adult dosing per label: begin with 50 mg daily (1 tablet) for 5 days, started on or about day 5 of the cycle; increase only in patients who do not ovulate. If ovulation does not occur, a second course of 100 mg daily for 5 days may be given as early as 30 days after the previous course, after excluding pregnancy. Doses beyond 100 mg/day for 5 days are not recommended. Further treatment is not recommended if ovulation does not occur after three courses, or if three ovulatory responses occur without pregnancy. Long-term cyclic therapy is not recommended beyond about six cycles. Final dosing is determined by the physician.
- Treatment should be supervised by physicians experienced in gynecologic or endocrine disorders
- Pelvic examination is necessary before the first and each subsequent course
- Confirm adequate endogenous estrogen, normal liver function, and absence of pregnancy and ovarian cysts
- A lower dose or shorter course is recommended when unusual sensitivity to gonadotropin is suspected, such as in polycystic ovary syndrome
- Ovulation most often occurs 5 to 10 days after a course
- With any visual symptoms: discontinue and obtain a full ophthalmological evaluation
🎓 Key points for students
- Nonsteroidal ovulatory stimulant (mixture of cis and trans isomers)
- Mechanism: estrogen-receptor competition, increased gonadotropins, follicle growth, ovulation
- Main indication: ovulatory dysfunction in women desiring pregnancy, especially polycystic ovary syndrome
- Contraindications: pregnancy, liver disease, undiagnosed abnormal uterine bleeding, ovarian cysts, uncontrolled thyroid/adrenal dysfunction, intracranial lesions
- Key adverse effects: ovarian enlargement, vasomotor flushes, visual symptoms, ovarian hyperstimulation syndrome
- Not recommended beyond about 6 treatment cycles
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is clomiphene used for?
It is used to treat ovulatory dysfunction in women who wish to become pregnant, after other impediments to pregnancy have been excluded or treated.
When does ovulation occur after taking it?
Ovulation most often occurs 5 to 10 days after a course of treatment, and intercourse should be timed accordingly as advised by your doctor.
Can clomiphene affect vision?
Yes, it may occasionally cause blurred vision, flashes, or spots, which can increase with higher dose or longer treatment. If any visual symptoms occur, stop the drug, see your doctor for an eye evaluation, and avoid driving if affected.
How long can it be used?
Long-term cyclic therapy is not recommended beyond about six cycles; your doctor will decide the number of cycles based on your response.
Can it be taken during pregnancy?
No, it is contraindicated in pregnancy. If you become pregnant while taking it, inform your doctor immediately.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-06), simplified. Updated: 2026-11-15.